CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-05 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant or award 10b5-1 | +1,522 | 151,400 | ||
| 2025-02-05 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award 10b5-1 | +1,675 | 156,707 | ||
| 2025-02-03 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −3,500 | $175.39 | $614K | 110,631 |
| 2025-02-03 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −17,140 | $176.61 | $3.0M | 93,491 |
| 2025-02-03 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −21,362 | $177.25 | $3.8M | 72,129 |
| 2025-02-03 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,500 | $178.19 | $267K | 70,629 |
| 2025-01-31 | Chapman Steven Leonard CEO AND PRESIDENT | Grant or award | +36,682 | 290,626 | ||
| 2025-01-31 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Grant or award 10b5-1 | +12,720 | 114,531 | ||
| 2025-01-31 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −400 | $173.05 | $69K | 114,131 |
| 2025-01-31 | Sheena Jonathan Director | Grant or award | +3,549 | 263,489 | ||
| 2025-01-31 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Grant or award | +29,345 | 2,412,522 | ||
| 2025-01-31 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Grant or award | +10,353 | 223,373 | ||
| 2025-01-31 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant or award | +12,720 | 148,203 |
Page 55 of 55 · 1,093 trades